ArunA Bio, Inc. — Form D/A

ArunA Bio, Inc. of ATHENS, GA, a company, filed a Form D amendment with the SEC on 2017-04-28. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (31)

Showing 25 of 31 people.

NameRoleLocation
Darren F DevoreDirectorAtlanta, GA
Harold W IngallsDirectorAlpharetta, GA
Russell C LindnerDirectorWashington, DC
John F Mangan, Jr.DirectorCharlotte, NC
Steven W SticeDirectorAthens, GA
Barry W StoreyDirectorAugusta, GA
Harold W IngallsExecutive OfficerAlpharetta, GA
Steven W SticeExecutive OfficerAthens, GA
Tracey W SticeExecutive OfficerAthens, GA
Darren DeVoreDirectorAtlanta, GA
C. William GriffinDirectorAthens, GA
Harold IngallsDirectorAthens, GA
Mason IrvingDirectorAthens, GA
John ManganDirectorAthens, GA
Russell LindnerDirectorAthens, GA
Mark SirgoDirectorAthens, GA
Mark SirgoExecutive OfficerAthens, GA
Steven SticeDirectorAthens, GA
Steven SticeExecutive OfficerAthens, GA
Tracey SticeExecutive OfficerAthens, GA
Barry StoreyDirectorAthens, GA
Al MedwarExecutive OfficerAthens, GA
Harold William IngallsDirectorATHENS, GA
Barry William StoreyDirectorATHENS, GA
C. William GriffinDirectorATHENS, GA

Other filings by this issuer (3)

FiledFormOfferingSold
2019-08-01D$13.3M$13.3M
2018-07-19D$6.0M$5.4M
2016-08-24D$1.2M$1.2M

More